Is this you? Create Your Porfile
Avatar

Mark G. Currie

Sunovion

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Mark G. Currie is active.

Explore More

Publication

Featured researches published by Mark G. Currie.

Bioorganic & Medicinal Chemistry Letters | 2008

In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.

Liming Shao; Michael Charles Hewitt; Thomas P. Jerussi; Frank Xinhe Wu; Scott Christopher Malcolm; Paul Grover; Kevin Q. Fang; Patrick Koch; Chris H. Senanayake; Nandkumar N. Bhongle; Seth Ribe; Roger P. Bakale; Mark G. Currie

Tramadol is a centrally acting opioid analgesic structurally related to codeine and morphine. O-Alkyl, N-desmethyl, and non-phenol containing derivatives of tramadol were synthesized to probe their effect on metabolic stability and both in vitro and in vivo potency.

Arthritis & Rheumatism | 2002

Cyclooxygenase 2‐dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants

Medora M. Hardy; Karen Seibert; Pamela T. Manning; Mark G. Currie; B. Mark Woerner; Dorothy Edwards; Alane T. Koki; Catherine S. Tripp

Archive | 2003

Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide

Thomas P. Jerussi; Qun Kevin Fang; Mark G. Currie

Archive | 2002

Tramadol analogs and uses thereof

Chris H. Senanayake; Thomas P. Jerussi; Paul Grover; Qun Kevin Fang; Mark G. Currie

Archive | 2002

D-amino acid oxidase inhibitors for learning and memory

Donald L. Heefner; Mark G. Currie; Richard F. Rossi; Charles M. Zepp

Archive | 2010

Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine

Thomas P. Jerussi; Qun Kevin Fang; Mark G. Currie

Archive | 2008

Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists

Mark G. Currie; Steve Jones; Paul Grover; Chris H. Senanayake; Q.Kevin Fang

Archive | 2002

Methods of using norfluoxetine

Mark G. Currie; Steven W. Jones; Chrisantha H. Senanayake; Zhi-hiu Lu

Archive | 2002

Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites

Chris H. Senanayake; Thomas P. Jerussi; Mark G. Currie; Qun K. Fang; Bob Hsu

Archive | 2004

Methods for treating depression and other CNS disorders using enantiomerically enriched desmethyl-and didesmethyl-metabolites of citalopram

Larry R. Bush; Mark G. Currie; Qun Kevin Fang; Chris H. Senanayake

Explore More

Collaboration

Dive into the Mark G. Currie's collaboration.

Top Co-Authors
Avatar

Thomas P. Jerussi

Sunovion

View shared research outputs
Top Co-Authors
Avatar

Qun Kevin Fang

Sunovion

View shared research outputs
Top Co-Authors
Avatar

Chris H. Senanayake

Boehringer Ingelheim

View shared research outputs
Top Co-Authors
Avatar

Charles M. Zepp

Sunovion

View shared research outputs
Top Co-Authors
Avatar

Steven W. Jones

Sunovion

View shared research outputs
Top Co-Authors
Avatar

Paul Grover

Sunovion

View shared research outputs
Top Co-Authors
Avatar

Steve Jones

Sunovion

View shared research outputs
Top Co-Authors
Avatar

Donald L. Heefner

Sunovion

View shared research outputs
Top Co-Authors
Avatar

Paul D. Rubin

Sunovion

View shared research outputs
Top Co-Authors
Avatar

Paul T. Grover

Indiana University Bloomington

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge